GS-6615 in Adults With Chronic Stable Angina and Coronary Artery Disease

NCT02377336 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped Anticipated recruitment challenges

Conditions

Ischemic Heart Disease

Interventions

DRUG: GS-6615
DRUG: Placebo

Sponsor

Gilead Sciences